BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6487492)

  • 1. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Mitchell SC; Waring RH; Haley CS; Idle JR; Smith RL
    Br J Clin Pharmacol; 1984 Oct; 18(4):507-21. PubMed ID: 6487492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of proposed sulphoxidation pathways of carbocysteine in man by HPLC quantification.
    Brockmöller J; Staffeldt B; Roots I
    Eur J Clin Pharmacol; 1991; 40(4):387-92. PubMed ID: 2050173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation of the metabolism of S-carboxymethyl-L-cysteine in man using a novel HPLC-ECD method.
    Karim EF; Millership JS; Temple DJ; Woolfson AD
    Eur J Drug Metab Pharmacokinet; 1988; 13(4):253-6. PubMed ID: 3243319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man.
    Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Biochem Pharmacol; 1982 Oct; 31(19):3151-4. PubMed ID: 7150344
    [No Abstract]   [Full Text] [Related]  

  • 5. Lack of congruence of S-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian population.
    Haley CS; Waring RH; Mitchell SC; Shah RR; Idle JR; Smith RL
    Xenobiotica; 1985 May; 15(5):445-50. PubMed ID: 4036168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals.
    Waring RH; Mitchell SC; O'Gorman J; Fraser M
    Biochem Pharmacol; 1986 Sep; 35(18):2999-302. PubMed ID: 3753512
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacogenetics of the S-oxidation of S-carboxymethyl-L-cysteine.
    Waring RH
    Drug Metabol Drug Interact; 1988; 6(3-4):253-63. PubMed ID: 3078290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.
    Watson RG; Olomu A; Clements D; Waring RH; Mitchell S; Elias E
    J Hepatol; 1988 Aug; 7(1):72-8. PubMed ID: 3183354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphic sulphoxidation of carbocisteine.
    Meese CO; Hofmann U; Eichelbaum M
    Lancet; 1990 Sep; 336(8716):693-4. PubMed ID: 1975882
    [No Abstract]   [Full Text] [Related]  

  • 10. Variation in human metabolism of S-carboxymethylcysteine.
    Waring RH
    Eur J Drug Metab Pharmacokinet; 1980; 5(1):49-52. PubMed ID: 7389752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man.
    Waring RH; Harris RM; Steventon GB; Mitchell SC
    Drug Metabol Drug Interact; 2003; 19(4):241-55. PubMed ID: 14768973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically determined impaired drug sulphoxidation.
    Waring RH; Mitchell SC; Idle JR; Smith RL
    Lancet; 1981 Apr; 1(8223):778. PubMed ID: 6110975
    [No Abstract]   [Full Text] [Related]  

  • 13. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation.
    Meese CO; Fischer P
    Z Naturforsch C J Biosci; 1990; 45(11-12):1171-5. PubMed ID: 2095787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.
    Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH
    J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphoxidation of S-carboxymethyl-L-cysteine in the rhesus monkey (Macaca mulatta), cynomologus monkey (Macaca fascicularis), African green monkey (Cercopithecus aethiops) and the marmoset (Callithrix jacchus).
    Mitchell SC; Waring RH; Wilson VL; Idle JR; Autrup H; Harris CC; Ritchie JC; Crothers MJ; Sieber SM
    Comp Biochem Physiol B; 1986; 84(2):143-4. PubMed ID: 3089678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphoxidation and sulphation capacity in patients with primary biliary cirrhosis.
    Davies MH; Ngong JM; Pean A; Vickers CR; Waring RH; Elias E
    J Hepatol; 1995 May; 22(5):551-60. PubMed ID: 7650336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.
    Panagopoulos P; Mitchell SC; Steventon GB
    Xenobiotica; 2015; 45(12):1047-53. PubMed ID: 26068525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation studies in women using combination type of oral contraceptives.
    Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
    J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism of S-carboxymethyl-L-cysteine in man: isolation of an ester glucuronic acid conjugate from urine.
    Waring RH; Mitchell SC; Shah RR
    Xenobiotica; 1983 May; 13(5):311-7. PubMed ID: 6636828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.